We have previously demonstrated that CTLA-4 is immune dysregulated in breast cancer and there is a significant increase of CTLA-4 expression not only by T cells from breast cancer patients but also by breast cancer cells themselves. The gene discussed is CTLA4; the disease is breast carcinoma.